Table 3.

Baseline characteristics, treatment-related variables, and long-term outcomes in all patients with clinical stage I NSCLC who received sublobar resection (wedge resection or segmentectomy) vs. SBRT. This table shows an unmatched comparison.

	Surgery (n=26292)		SBRT (n=5887)		P value
Age (years)	70.1 ± 9.3		74.7 ± 8.7		<.001
Female Gender	14670 (55.8%)		3208 (54.5%)		0.070
Caucasian	24016 (91.3%)		5354 (90.9%)		0.332
Urban Location	17710 (67.4%)		3998 (67.9%)		0.415
Income >$35000/year	17172 (68.8%)		3806 (68.0%)		0.202
Charlson/Deyo Score (available total n=25846, surgery 19959, SBRT 5887)	0	9087 (45.5%)	0	3489 (59.3%)	<.001
	1	7662 (38.4%)	1	1603 (27.2%)
	2	3211 (16.1%)	2	795 (13.5%)
Tumor Size (mm)	19.3 ± 9.0		23.4 ± 9.5		<.001
Clinical T stage	T1	80184 (71.8%)	T1	4477 (76.0%)	<.001
	T2	31547 (28.2%)	T2	1410 (24.0%)
Facility Reporting Case	Nonacademic 16353 (62.2%)		Nonacademic 3470 (58.9%)		<.001
	Academic 9939 (37.8%)		Academic 2417 (41.1%)
Type of operation	Wedge 22010 (83.7%) Segment 4282 (16.3%)
Chemotherapy administered	2193 (8.4%)		241 (4.1%)		<0.001
Radiation administered	2015 (7.7%)		5887 (100%)		<0.001
Median radiation dose (cGy)	5750 (n=1033)		5400 (n=5887)
Median Survival (months)	51.9 ± 0.5		33.3 ± 0.8		<.001